🔥🐔 BizChicken 🐔🔥
Companies Similar to IDEAYA Biosciences, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Lyell Immunopharma, Inc.
LYL797, LYL845, NY-ESO-1
Lyell Immunopharma, Inc. is a biopharmaceutical company developing T cell therapies focused on treating patients with solid tumors using advanced genetic and epigenetic reprogramming technologies.
About | Our Story | Vision/Values | Our Story | Leadership | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: LYEL
Recent Price: $0.62
Industry: Biotechnology
CEO: Dr. Lynn Seely M.D., Ph.D.
Sector: Healthcare
Employees: 224
Address: 201 Haskins Way, South San Francisco, CA 94080
Phone: 650 695 0677
Leadership
- Lynn Seely, M.D., President & Chief Executive Officer
- Stephen Hill, Chief Operating Officer
- Matthew Lang, J.D., Chief Business Officer
- Gary Lee, Ph.D., Chief Scientific Officer
- Charles Newton, Chief Financial Officer
- Ellen Rose, Senior Vice President, Investor Relations and Communications
- Bryan Selby, Senior Vice President, Clinical Development Operations
- Ann Tomlin, Senior Vice President, Human Resources
- Rick Klausner, M.D., Founder & Board Chair
- Crystal Mackall, M.D., Founder
- Stan Riddell, M.D., Founder
- Hans Bishop, Director
- Otis Brawley, M.D., Director
- Catherine Friedman, Director
- Elizabeth Nabel, M.D., Director
- Robert Nelsen, Director
- William Rieflin, Director
Last updated: 2024-12-31
Ikena Oncology, Inc.
IK-930
Ikena Oncology is a targeted oncology company developing medicines tailored to biomarker-defined patient groups, with a focus on unmet needs in cancer treatment.
Symbol: IKNA
Recent Price: $1.60
Industry: Biotechnology
CEO: Dr. Mark Manfredi Ph.D.
Sector: Healthcare
Employees: 18
Address: 645 Summer Street, Boston, MA 02210
Phone: 857 273 8343
Last updated: 2024-12-31
Pyxis Oncology, Inc.
PYX-106, PYX-102, PYX-201, PYX-202, PYX-203
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.
Symbol: PYXS
Recent Price: $1.56
Industry: Biotechnology
CEO: Dr. Lara S. Sullivan M.D., MBA
Sector: Healthcare
Employees: 55
Address: 35 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 221 9059
Last updated: 2024-12-31
Sensei Biotherapeutics, Inc.
Immuno Phage platform
Sensei Biotherapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of immunotherapies for cancer, leveraging platforms such as Immuno Phage and Tumor Microenvironment Activated Biologics.
Symbol: SNSE
Recent Price: $0.48
Industry: Biotechnology
CEO: Mr. John K. Celebi M.B.A.
Sector: Healthcare
Employees: 28
Address: 451 D Street, Rockville, MD 02210
Phone: 240 243 8000
Last updated: 2024-12-31
Tenaya Therapeutics, Inc.
TN-201, TN-301, TN-401
Tenaya Therapeutics, Inc. is a biotechnology company that discovers, develops, and delivers therapies for heart disease using cellular regeneration, gene therapy, and precision medicine platforms.
Symbol: TNYA
Recent Price: $1.45
Industry: Biotechnology
CEO: Mr. Faraz Ali M.B.A.
Sector: Healthcare
Employees: 140
Address: 171 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 825 6900
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
Beam Therapeutics Inc.
precision genetic medicines
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States, with a focus on conditions such as sickle cell disease, beta thalassemia, and Glycogen Storage Disease Type Ia.
About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About | About | Careers | About | Jobs | Careers
Symbol: BEAM
Recent Price: $25.28
Industry: Biotechnology
CEO: Mr. John M. Evans M.B.A.
Sector: Healthcare
Employees: 472
Address: 238 Main Street, Cambridge, MA 02142
Phone: 857 327 8775
Last updated: 2024-12-31
Biomea Fusion, Inc.
BMF-219
Biomea Fusion, Inc. is a biopharmaceutical company specializing in the discovery and development of covalent small molecule drugs for patients with genetically defined cancers and metabolic diseases. Their lead product candidate, BMF-219, targets multiple cancers.
Symbol: BMEA
Recent Price: $3.88
Industry: Biotechnology
CEO: Mr. Thomas Andrew Butler
Sector: Healthcare
Employees: 107
Address: 900 Middlefield Road, Redwood City, CA 94063
Phone: 650 980 9099
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Coherus BioSciences, Inc.
UDENYCA
Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.
Symbol: CHRS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Dennis M. Lanfear
Sector: Healthcare
Employees: 306
Address: 333 Twin Dolphin Drive, Redwood City, CA 94065
Phone: 650 649 3530
Last updated: 2024-12-31
Day One Biopharmaceuticals, Inc.
DAY101
Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for genetically defined cancers. Their lead product candidate is DAY101, currently in Phase II clinical trials for pediatric patients with low-grade glioma.
Vision/Values | Leadership | About | Contact | About | Leadership | Leadership | Leadership | Leadership | Leadership | About | About
Symbol: DAWN
Recent Price: $12.58
Industry: Biotechnology
CEO: Dr. Jeremy Bender M.B.A., Ph.D.
Sector: Healthcare
Employees: 174
Address: 395 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 484 0899
Leadership
- Samuel Blackman, MD, PhD, Head of R&D
- Elly Barry, MD, Chief Medical Officer
- Jeremy Bender, PhD, MBA, Director
- Davy Chiodin, PharmD, Chief Development Officer
- Adam Dubow, General Counsel
- Lauren Merendino, MBA, Chief Commercial Officer
- John Stubenrauch, Chief Technology Officer
- Jaa Roberson, Chief People Officer
- Charles N. York II, MBA, Chief Operating and Financial Officer
- Garry Nicholson, MBA, Chair
- Habib Dable, Director
- Scott Garland, Director
- Michael Gladstone, Director
- William Grossman, MD, PhD, Director
- Natalie Holles, Director
- John A. Josey, PhD, MBA, Director
- Saira Ramasastry, MS, MPhil, Director
Last updated: 2024-12-31
4D Molecular Therapeutics, Inc.
4D-125, 4D-110, 4D-310, 4D-150, 4D-710
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.
About | About | Contact | News | News | News | Careers | Careers | About | DEI | Careers | Leadership | Careers | Careers
Symbol: FDMT
Recent Price: $5.30
Industry: Biotechnology
CEO: Dr. David H. Kirn M.D.
Sector: Healthcare
Employees: 201
Address: 5858 Horton Street, EmeryVille, CA 94608
Phone: 510 505 2680
Last updated: 2024-12-31
LogicBio Therapeutics, Inc.
LB-001
Logic Bio Therapeutics, Inc. is a genetic medicine company focused on genome editing and gene therapy treatments using its Gene Ride and s AAVy platforms. Its lead product candidate, LB-001, is in clinical trials for methylmalonic acidemia.
About | Leadership | DEI | History | About | About | Safety | Contact | Careers | Careers | Benefits | Culture | Careers | DEI | Careers | Careers | Locations | Jobs | Site Map | Management | Careers | About | About | About | About | About | About | About | About | About | About
Symbol: LOGC
Recent Price: $7.08
Industry: Biotechnology
CEO: Mr. Rishi Bajaj
Sector: Healthcare
Employees: 452
Address: 65 Hayden Ave, 2Nd Floor, Lexington, MASSACHUSETTS 02421
Phone: 16172450399
Last updated: 2024-12-31
Phio Pharmaceuticals Corp.
INTASYL therapeutic platform
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.
Symbol: PHIO
Recent Price: $1.90
Industry: Biotechnology
CEO: Mr. Robert J. Bitterman
Sector: Healthcare
Employees: 8
Address: 257 Simarano Drive, Marlborough, MA 01752
Phone: 508 767 3861
Last updated: 2024-12-31
Sana Biotechnology, Inc.
N/A
Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.
Symbol: SANA
Recent Price: $1.61
Industry: Biotechnology
CEO: Dr. Steven D. Harr M.D.
Sector: Healthcare
Employees: 328
Address: 188 East Blaine Street, Seattle, WA 98102
Phone: 206 701 7914
Last updated: 2024-12-31
Synlogic, Inc.
Synthetic Biotic Medicines
Synlogic, Inc. is a clinical-stage biopharmaceutical company focused on the development of synthetic biotic medicines to treat metabolic and immunological diseases. The company's pipeline includes drug candidates for conditions such as phenylketonuria, homocystinuria, enteric hyperoxaluria, and solid tumors and lymphoma.
Symbol: SYBX
Recent Price: $1.40
Industry: Biotechnology
CEO: Mr. Antoine Awad
Sector: Healthcare
Employees: 6
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 401 9975
Last updated: 2024-12-31
2seventy bio, Inc.
idecabtagene vicleucel
2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.
Symbol: TSVT
Recent Price: $2.89
Industry: Biotechnology
CEO: Mr. William D. Baird III, M.B.A.
Sector: Healthcare
Employees: 274
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
IDEAYA Biosciences, Inc.
IDE397 and IDE196
IDEAYA Biosciences, Inc. is a precision medicine oncology company that focuses on developing targeted therapeutics for specific patient populations using molecular diagnostics. Key product candidates include IDE397 and IDE196, aimed at treating genetically defined cancers.
Symbol: IDYA
Recent Price: $24.93
Industry: Biotechnology
CEO: Mr. Yujiro S. Hata
Sector: Healthcare
Employees: 124
Address: 7000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 443 6209
Last updated: 2024-12-31
Ionis Pharmaceuticals, Inc.
RNA-targeted therapeutics
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States, offering treatments like SPINRAZA, TEGSEDI, and WAYLIVRA, while developing medicines in phase 3 studies for various indications including TTR amyloidosis, severe hypertriglyceridemia, and amyotrophic lateral sclerosis.
About | About | About | DEI | DEI | DEI | DEI | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | About | About | News | About | About | ESG | DEI | DEI | About | About | About | Management | About | About | About | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | ESG | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About | About | About | Jobs | About | About
Symbol: IONS
Recent Price: $34.92
Industry: Biotechnology
CEO: Dr. Brett P. Monia Ph.D.
Sector: Healthcare
Employees: 927
Address: 2855 Gazelle Court, Carlsbad, CA 92010
Phone: 760 931 9200
Last updated: 2024-12-31